Novotech Named a Fierce CRO Award Winner in the Excellence in Clinical Trial Management and Global Operations Categories
Reading Time: 3 minutes Sydney, Australia: Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, today announced it was named a Fierce CRO Award winner by
Boyd Watterson Names Don Haisch as Global Chief Financial Officer
Reading Time: 3 minutes Cleveland, United States: Boyd Watterson Asset Management is pleased to announce the appointment of Don Haisch as its new Global Chief Financial Officer (CFO), marking a pivotal milestone following the strategic combination of Boyd Watterson and Amber Infrastructure. This newly created
AstaGuru Announces Two Extraordinary Auctions Featuring Rare Collectibles and Fine Jewellery & Watches
Reading Time: 3 minutes AstaGuru Auction House is set to conclude the year with two spectacular online auctions that celebrate timeless artistry and craftsmanship. The Heirloom Collectibles: Antiques & Silver Auction, taking place on December 18-19, 2024, will showcase a stunning collection of rare antiques and exquisite silverware. This will
Biocodex Strengthens Supply Chain Resilience with Kinaxis
Reading Time: 2 minutes Ottawa, Ontario, Canada: Biocodex, a pioneer and leader in human microbiota health, as well as an innovator in pharmaceuticals, has partnered with Kinaxis® Inc. (TSX: KXS), a global leader in end-to-end supply chain orchestration, to modernize and optimize its processes. Through
SINOVAC Initiated a Phase III Clinical Trial on Bivalent Vaccine Against Hand Foot and Mouth Disease (HFMD)
Reading Time: 3 minutes Beijing, China: Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III clinical trial on a vaccine candidate to prevent HFMD caused by both Enterovirus
Biocytogen Announces Adcendo ApS Exercises Antibody Option to Accelerate ADC Development
Reading Time: 2 minutes Beijing, China: Adcendo exercises its option to utilize Biocytogen’s fully human antibodies to further expand its ADC pipeline for cancers with high unmet medical need This collaboration further validates Biocytogen’s proprietary RenMice® antibody discovery platform, demonstrating its potential to
TECNO Redefines Art Through Technology as the ‘Co-Powered by Partner’ for DPIFF 2025
Reading Time: 4 minutes Mumbai, Maharashtra, India: TECNO, the global smartphone brand known for its innovative technology, is a proud partner of DPIFF 2025, honouring the rich cultural heritage of Indian cinema. Aligned with its commitment to delivering best-in-class features at an accessible price point,
Motorola Announces the Sale of moto g35 5G – The Segment’s Fastest* 5G Smartphone with 12 5G Bands, Segment’s Only FHD+ 6.7″ 120Hz Display and Segment’s Only 50MP Camera with 4K Video Recording at an Effective Price of Just Rs. 9,999 on Flipkart, Motorola.in and Leading Retail Stores
Reading Time: 3 minutes Motorola, India’s best# 5G smartphone brand, recently announced the launch of the segment’s fastest* 5G smartphone moto g35 5G to disrupt the affordable 5G smartphone market. This smartphone was launched with the segment’s highest 12 5G bands, which is also validated by Techarc as India’s fastest
The Global Loan Agency Services Group (“GLAS”) is delighted to confirm the successful completion of its acquisition of Watiga Trust and Watiga Asia (collectively, “Watiga”).
Reading Time: 3 minutes Singapore: The Global Loan Agency Services Group (“GLAS”) is delighted to confirm the successful completion of its acquisition of Watiga Trust and Watiga Asia (collectively, “Watiga”). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241215004425/en/
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
Reading Time: 3 minutes Mont-Saint-Guibert, Belgium & TOKYO, Japan: BrightPath Bio (Tokyo Stock Exchange Growth 4594, “BrightPath”), a pioneer in iPS cell-derived Natural Killer T (“NKT”) cell therapy, and Cellistic, a leader in advanced iPS cell therapy manufacturing, today announced a process development and manufacturing